APMI

GROWTH

Investment Approach Details

₹433.94

(AUM CR)

PMS Provider Name

Molecule Ventures Limited Liability Partnership

Benchmark

S&P BSE 500 TRI

Strategy Name

Equity

Product Name

Equity

Date Of Inception

31/05/2021

Age

3.11 Years

Min. Inv. Amount

5000000

Fixed Fees Structure

NIL

Variable Fees Structure

Profit Sharing:20%

Exit Load

NIL

Purpose

The primary objective of the fund is to achieve capital appreciation through medium to long term investments in quality companies with strong growth prospects, mostly in the Mid and Small Cap.

Fund Manager Details


Nirav Parikh
Work Exp. NA
Email ID nirav@moleculeventures.in
Mobile No NA
Details NA

Period-Wise Performance

IA vs. Benchmark Performance

Turnover Details As On 31/03/2024

1 Month Turnover

0.13

1 Year Turnover

0.77